ARCHIVES

Oncologists Don’t Demand Increased Survival When Ordering Expensive Drugs, Survey Finds

This article is from The Cancer Letter archive.

Vol. 38 No. 15 | April 13, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Spent $381.2 Million On PR From 2006 to 2012, Vastly Outspending Other NIH, FDA Units

March 1, 2013

NCI Programs: NCI Drug Screening To Take More Targeted Approach; BSA Okays Plan To Support New MA Contracts

April 3, 1998

NCI Diet Guideline Outlined At Senate Hearing

November 22, 1985

Senate Committee Approves $27 Billion for NIH, $4.6 Billion for NCI

August 2, 2002

Phase III Trial of ThermoDox Fails to Meet Primary Endpoint

February 22, 2013

Interferon Interest Zooms; NCI Awarding Production Contracts, Proceeds With Plans For Clinical Trials

March 14, 1980